Revenue (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Three Months Ended March 31,
	2025		2024
Patient services
Capitated revenue	$	17,495	$	17,667
FFS revenue	35,573		34,786
Subtotal	53,068		52,453
Dispensary revenue	49,293		39,679
Clinical research trials and other revenue	2,045		2,534
Total	$	104,406	$	94,666